New Technologies for Liver Disease STTR (R41/R42)

The summary for the New Technologies for Liver Disease STTR (R41/R42) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
New Technologies for Liver Disease STTR (R41/R42): The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to develop resources, research tools, instrumentations, biomarkers, devices, drugs or new and innovative approaches to diagnosis, monitoring, management, treatment and prevention of liver diseases. Areas of interest include development of reliable and practical means of diagnosis of liver diseases; biomarkers for disease activity and stage; noninvasive tests for inflammation, fibrosis and fat in the liver; and drugs, complementary and alternative modalities, biologics or molecular reagents for the therapy or prevention of liver diseases. The goal of this announcement is to enlist members of the small business research community in advancing means of diagnosis, treatment and prevention of liver disease and facilitate the goals outlined in the trans-NIH Action Plan for Liver Disease Research. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. -This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-06-397 that solicits applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms. -Eligible organizations: Only United States SBCs are eligible to submit STTR applications. A SBC is one that, on the date of award for both Phase I and Phase II funding agreements, meets ALL of the criteria as described in Section III. -Eligible individuals: Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. On an STTR application, the Project Director/Principal Investigator (PD/PI) may be employed with the SBC or the participating non-profit research institution as long as he/she has a formal appointment with or commitment to the applicant SBC, which is characterized by an official relationship between the small business concern and that individual. -Applicant SBCs may submit more than one application, provided each application is scientifically distinct.
Federal Grant Title: New Technologies for Liver Disease STTR (R41/R42)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Food and Nutrition Health Environment
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-06-396
Type of Funding: Grant
CFDA Numbers: 93.11493.213
CFDA Descriptions: Applied Toxicological Research and Testing 93.213 Research and Training in Complementary and Alternative Medicine
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: May 08, 2006
Creation Date: May 09, 2006
Archive Date: Feb 01, 2009
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.273 -- Alcohol Research Programs
Applicants Eligible for this Grant
Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are not eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020